Compare GDS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDS | STVN |
|---|---|---|
| Founded | 2001 | 1949 |
| Country | China | Italy |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.4B |
| IPO Year | 2016 | 2021 |
| Metric | GDS | STVN |
|---|---|---|
| Price | $42.24 | $21.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $46.20 | $23.75 |
| AVG Volume (30 Days) | ★ 1.2M | 246.8K |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | ★ 3.59 | 0.60 |
| Revenue | ★ $1,573,383,809.00 | $1,373,219,524.00 |
| Revenue This Year | $13.03 | $8.42 |
| Revenue Next Year | $12.55 | $8.77 |
| P/E Ratio | $44.83 | ★ $36.42 |
| Revenue Growth | ★ 11.86 | 6.97 |
| 52 Week Low | $16.93 | $17.81 |
| 52 Week High | $52.50 | $28.00 |
| Indicator | GDS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 74.16 | 53.48 |
| Support Level | $36.34 | $20.09 |
| Resistance Level | $38.79 | $21.91 |
| Average True Range (ATR) | 1.30 | 0.65 |
| MACD | 0.56 | 0.23 |
| Stochastic Oscillator | 96.81 | 87.96 |
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.